Algernon Pharmaceuticals Inc.
Algernon Pharmaceuticals is a drug re-purposing company that investigates safe, already approved drugs for new disease applications, moving them efficiently and safely into new human trials, developing new formulations and seeking new regulatory approvals in global markets. Algernon specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off label prescription writing.
Algernon Pharmaceuticals Inc. (AGN)
le 19 janvier/January 2021
Further to Bulletin 2020-1240, Algernon Pharmaceuticals Inc. warrants will expire on January 21, 2021.
Settlement Terms: All trades January 19th and 20th will settle for cash next day. Trades on January 21 will be for cash same day.
The warrants will be halted at noon and delisted at market close January 21, 2021.